Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 56.40% vs -0.37% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 43.96% vs 145.95% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 27.81% vs 277.50% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 160.00% vs 66.67% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Eiko Lifescience With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -8.67% vs 53.09% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 56.40% vs -0.37% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 0.77% vs 7.44% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 43.96% vs 145.95% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -15.35% vs 21.28% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 27.81% vs 277.50% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 8.33% vs 71.43% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 160.00% vs 66.67% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






